All conditions

YOUR CONDITION, EXPLAINED

Multiple Myeloma VA disability rating & claim guide

The VA rates Multiple Myeloma under diagnostic code 7712, in 38 CFR § 4.117 (hemic and lymphatic systems), and the schedule provides two evaluation levels for it: 100% and 0%.

DC 7712Hemic and Lymphatic SystemsData last updated September 23, 2026

Free · No account needed

Save your Multiple Myeloma guide

Email yourself this Multiple Myeloma guide so the rating criteria, evidence checklist, and preparation tips are easy to find later.

A CLEARER PATH FORWARD

Make sense of your next step.

01Understand the rating02Know what to gather03Plan your preparation
Based on 38 CFR Part 4Free condition guideTake it one step at a time

THE ESSENTIALS

How the VA rates Multiple Myeloma

DC 7712 has two evaluations and one word divides them: symptomatic. Symptomatic multiple myeloma is 100 percent; asymptomatic or smoldering myeloma, and monoclonal gammopathy of undetermined significance (MGUS), are 0 percent. Note (1) says what may be used to establish which of the two applies — current validated biomarkers as defined by the American Society of Hematology and the International Myeloma Working Group. And Note (2) is the provision that separates this code from every other cancer code in Part 4: the 100 percent continues for FIVE YEARS after the diagnosis of symptomatic multiple myeloma, not six months after treatment ends, at which point a mandatory VA examination determines the evaluation — with 38 CFR 3.105(e) and 38 CFR 3.344(a) and (b) applying to any reduction.

DC 7712 states two evaluations. 100 percent: symptomatic multiple myeloma. 0 percent: asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS). Note (1): current validated biomarkers of symptomatic multiple myeloma and of asymptomatic multiple myeloma, smoldering, or MGUS are acceptable for the diagnosis of multiple myeloma as defined by the American Society of Hematology (ASH) and the International Myeloma Working Group (IMWG). Note (2): the 100 percent evaluation shall continue for five years after the diagnosis of symptomatic multiple myeloma, at which time the appropriate disability evaluation shall be determined by mandatory VA examination, and any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR 3.105(e) and 38 CFR 3.344(a) and (b). Three things follow, and each one is unusual. First, the clock runs from DIAGNOSIS, not from treatment: the other malignancy codes in this part continue a total rating for a period after therapy is discontinued, so a veteran reading them alongside this one will expect a treatment-based interval and will be wrong. Second, the interval is five years rather than six months or two years, which is the longest protected period any code in § 4.117 provides. Third, Note (2) adds 38 CFR 3.344(a) and (b) to the usual 38 CFR 3.105(e) — those are the stabilized-rating provisions, and a rating that has continued at the same level for five years is exactly the case they are written about. The 0 percent tier is not a denial of the diagnosis. It is the evaluation the schedule assigns to asymptomatic and smoldering disease and to MGUS, and the difference between it and the total rating is whether the disease is symptomatic, which Note (1) allows to be established by validated biomarkers.

Diagnostic code
7712
Rating schedule
38 CFR § 4.117
Schedule levels
100% and 0%
How does the VA choose a rating level?

Which level applies is set by the criteria the evidence meets, not by the diagnosis. Where there is a question as to which of two evaluations applies, 38 CFR § 4.7 assigns the higher one if the disability picture more nearly approximates the criteria required for that rating.

EXPLORE THE PERCENTAGES

Multiple Myeloma VA rating criteria (DC 7712)

Choose a percentage to see what that level means. Open the full comparison to read all the criteria in one place.

VA RATING100%Multiple Myeloma

WHAT THIS LEVEL MEANS

Symptomatic disease. The code says nothing about treatment, stage or blood counts at this tier.

Explore 100% criteria & monthly pay
Multiple Myeloma: the criteria for each rating, quoted from 38 CFR § 4.117, DC 7712
Rating38 CFR criteria (quoted)In plain English (Vetrify’s summary)Monthly pay, 2026 (single veteran)
100%

“Symptomatic multiple myeloma”

Symptomatic disease. The code says nothing about treatment, stage or blood counts at this tier.$3,938.58
0%

“Asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS)”

Asymptomatic or smoldering myeloma, or MGUS. The code states this tier itself.No monthly payment

VA pays on the combined rating, not per condition: each amount is what a veteran with no dependents receives when that percentage is the combined rating, after all separate ratings are combined under 38 CFR 4.25.

These are published rating criteria. Selecting a level does not predict your VA decision.

IN THE REGULATION’S OWN WORDS

What 38 CFR also says about Multiple Myeloma

The notes 38 CFR Part 4 prints with these criteria, quoted. They govern how the evaluation is made without being a rating level themselves.

  • “Note (1): Current validated biomarkers of symptomatic multiple myeloma and asymptomatic multiple myeloma, smoldering, or monoclonal gammopathy of undetermined significance (MGUS) are acceptable for the diagnosis of multiple myeloma as defined by the American Society of Hematology (ASH) and International Myeloma Working Group (IMWG)”DC 7712
  • “Note (2): The 100 percent evaluation shall continue for five years after the diagnosis of symptomatic multiple myeloma, at which time the appropriate disability evaluation shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) and § 3.344 (a) and (b) of this chapter”DC 7712

BUILD YOUR EVIDENCE, ONE PIECE AT A TIME

Evidence for your Multiple Myeloma claim

A long list feels easier when you have a place to start. Use this checklist to see what you have and what still needs gathering.

Your evidence checklist

Check off what you’ve gathered. Progress stays on this page until you leave or refresh.

0 of 4 gathered

THE EXAM FORM

Which DBQ is used for Multiple Myeloma?

VA's page says: “You can use these forms to submit medical evidence from your health care providers.”

Source: VA: Public Disability Benefits Questionnaires (DBQs), read September 18, 2026.

SMALL DETAILS. BETTER PREPARATION.

Preparing your Multiple Myeloma claim

Start with the practical tips, then explore the common oversights. You don’t need to work through everything at once.

Practical tips for your claim4 tips
  • 01

    Establish the date of diagnosis of symptomatic disease in writing, early. Five years of a total evaluation run from it, and it is the fact most likely to be recorded imprecisely.

  • 02

    Diary the five-year mark. A mandatory VA examination falls there, and the evaluation from that point is determined by it.

  • 03

    Get the biomarker results into the file. Note (1) accepts them for the diagnosis as ASH and the IMWG define it, and they are how the symptomatic question is usually answered.

  • 04

    Read 38 CFR 3.344(a) and (b) alongside 3.105(e) before the five-year examination. They govern reductions in ratings that have been stable, which after five years this one has been.

C&P exam pitfalls to keep in mind4 tips
  • 01

    The five-year period measured from the end of treatment. Note (2) measures it from the diagnosis of symptomatic multiple myeloma, which is usually the earlier date and can be much earlier.

  • 02

    "Multiple myeloma" recorded without saying whether it is symptomatic. The two tiers of this code are separated by that word and by nothing else.

  • 03

    MGUS or smoldering myeloma treated as no diagnosis. The schedule assigns them a 0 percent evaluation under this code, which is a rating and a foundation for an increase later.

  • 04

    A reduction proposed at five years without 38 CFR 3.344 being applied. Note (2) names 3.344(a) and (b) alongside 3.105(e), and a rating that has run five years is what those provisions are about.

Common filing mistakes4 tips
  • 01

    Expecting the same six-month clock the other cancer codes use. This code is the exception in Part 4: five years, measured from diagnosis of symptomatic disease.

  • 02

    Not filing on MGUS or smoldering myeloma. The schedule gives them a stated 0 percent evaluation, which establishes service connection and is the thing an increase is later built on.

  • 03

    Arguing severity by blood counts or stage. Neither tier of this code mentions them; the criterion is whether the myeloma is symptomatic.

  • 04

    Accepting a reduction at the five-year examination without checking the stabilized-rating rules. Note (2) applies 38 CFR 3.344(a) and (b) as well as 3.105(e) to any reduction.

When symptoms may first appear2 tips
  • 01

    The schedule states no course of onset for this code, but it is the one code in § 4.117 whose protected period runs from a DIAGNOSIS rather than from the end of treatment.

  • 02

    The interval the regulation fixes is five years, counted from the diagnosis of symptomatic multiple myeloma to a mandatory VA examination. That is the longest protected period in the hemic and lymphatic schedule.

LET’S CLEAR A FEW THINGS UP

Common questions about Multiple Myeloma

Is Multiple Myeloma a VA-rated disability?

Yes. The VA rates Multiple Myeloma under VASRD diagnostic code 7712 (Hemic and Lymphatic Systems). DC 7712 has two evaluations and one word divides them: symptomatic. Symptomatic multiple myeloma is 100 percent; asymptomatic or smoldering myeloma, and monoclonal gammopathy of undetermined significance (MGUS), are 0 percent. Note (1) says what may be used to establish which of the two applies — current validated biomarkers as defined by the American Society of Hematology and the International Myeloma Working Group. And Note (2) is the provision that separates this code from every other cancer code in Part 4: the 100 percent continues for FIVE YEARS after the diagnosis of symptomatic multiple myeloma, not six months after treatment ends, at which point a mandatory VA examination determines the evaluation — with 38 CFR 3.105(e) and 38 CFR 3.344(a) and (b) applying to any reduction.

What VA disability rating can I get for Multiple Myeloma?

Possible VA ratings for Multiple Myeloma are 100%, 0%. Examples: 100%: Symptomatic multiple myeloma; 0%: Asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS).

What evidence helps prove Multiple Myeloma for VA disability?

Strong evidence for a Multiple Myeloma claim includes: The date of diagnosis of SYMPTOMATIC multiple myeloma, stated as such. Note (2)'s five-year period runs from that date, and it is the only date this code's continuation depends on; Findings establishing that the disease is symptomatic rather than smoldering or MGUS. That single distinction is the whole difference between the 100 percent and the 0 percent tiers; Biomarker results, which Note (1) accepts for the diagnosis as defined by the American Society of Hematology and the International Myeloma Working Group; For a claim at or past five years, records of the residuals. The mandatory examination at that point determines the appropriate evaluation, and what it evaluates is what is left.

Which DBQ is used for Multiple Myeloma?

VA's Hematologic and Lymphatic Conditions, Including Leukemia Disability Benefits Questionnaire (DBQ) is on its public list of DBQs. VA's page says: "You can use these forms to submit medical evidence from your health care providers."

What mistakes should veterans avoid when claiming Multiple Myeloma?

Common pitfalls when filing for Multiple Myeloma: Expecting the same six-month clock the other cancer codes use. This code is the exception in Part 4: five years, measured from diagnosis of symptomatic disease; Not filing on MGUS or smoldering myeloma. The schedule gives them a stated 0 percent evaluation, which establishes service connection and is the thing an increase is later built on; Arguing severity by blood counts or stage. Neither tier of this code mentions them; the criterion is whether the myeloma is symptomatic; Accepting a reduction at the five-year examination without checking the stabilized-rating rules. Note (2) applies 38 CFR 3.344(a) and (b) as well as 3.105(e) to any reduction.

Is Multiple Myeloma a presumptive condition for VA benefits?

Yes, for a veteran who meets a presumption's conditions. 38 CFR 3.309(e) names "Multiple myeloma" among the diseases associated with herbicide agents, for a veteran exposed to one during service. The regulation presumes that exposure for service in Vietnam, including its offshore waters, from January 9, 1962 to May 7, 1975; in a unit that, as the Department of Defense determined, operated in or near the Korean DMZ where herbicides were applied, from April 1, 1968 to August 31, 1971; or, in the Air Force or Air Force Reserve, regularly and repeatedly aboard C-123 aircraft used to spray herbicides (38 CFR 3.307(a)(6)). The statute, 38 U.S.C. 1116, 1116A and 1116B, also covers U.S. or Royal Thai bases in Thailand, Laos, Mimot or Krek in Cambodia, Guam or American Samoa or their territorial waters, Johnston Atoll or a ship that called there, and the DMZ from September 1, 1967, each in its own period. 38 CFR 3.309(f) names "Multiple myeloma" among the diseases associated with the water supply at Camp Lejeune, for a veteran, former reservist or member of the National Guard with at least 30 days of service in total, consecutive or not, at Camp Lejeune or Marine Corps Air Station New River between August 1, 1953 and December 31, 1987 (38 CFR 3.307(a)(7)). 38 CFR 3.309(d) names "Multiple myeloma" among the diseases specific to radiation-exposed veterans, whom 38 CFR 3.309(d)(3) defines by radiation-risk activity, such as onsite participation in an atmospheric nuclear test or the occupation of Hiroshima or Nagasaki from August 6, 1945 to July 1, 1946. VA's list of presumptive cancers related to burn pit exposure names "Multiple myelomas, including monoclonal gammopathy of undetermined significance (MGUS)" for a covered veteran of the Gulf War or post-9/11 service (38 U.S.C. 1119(c)): VA's own reading of 38 U.S.C. 1120(b), and by VA's note not a complete list. Each presumption gives way to affirmative evidence to the contrary (38 CFR 3.307(d); 38 U.S.C. 1113).

How long does the 100 percent for multiple myeloma last?

Five years from the diagnosis of symptomatic multiple myeloma, and this is the code in Part 4 most likely to be read wrong by someone comparing it to its neighbours. Every other malignancy code in the hemic and lymphatic schedule continues a total rating for a period after therapy is DISCONTINUED - six months for leukemia and Hodgkin's lymphoma, two years for non-Hodgkin's lymphoma. DC 7712's Note (2) instead says the 100 percent evaluation shall continue for five years after the diagnosis of symptomatic multiple myeloma, at which time the appropriate disability evaluation is determined by mandatory VA examination. Any reduction based on that or a later examination is subject to 38 CFR 3.105(e) and to 38 CFR 3.344(a) and (b), the stabilized-rating provisions, which a rating that has run five years squarely falls under.

Is MGUS or smoldering myeloma worth filing?

The schedule gives it a stated evaluation, which is not the same as nothing. DC 7712's 0 percent criterion is "asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS)", so a claim establishes service connection at 0 percent and the disease becoming symptomatic later is an increase on an existing rating rather than a new claim. Note (1) says current validated biomarkers of symptomatic and of asymptomatic, smoldering or MGUS disease are acceptable for the diagnosis as defined by the American Society of Hematology and the International Myeloma Working Group, so the distinction the two tiers turn on is one the laboratory record can answer.

Official sources

  1. 38 CFR § 4.117, Schedule of ratings, hemic and lymphatic systems (Diagnostic Code 7712)
  2. 38 CFR § 4.7, higher of two evaluations
  3. 38 CFR 3.309(e), presumptive service connection
  4. 38 CFR 3.309(f), presumptive service connection
  5. 38 CFR 3.309(d), presumptive service connection
  6. VA's list of presumptive cancers related to burn pit exposure, presumptive service connection

Criteria in quotation marks are the regulation’s own words; everything else on this page is Vetrify’s summary of it. The eCFR text is authoritative. See how Vetrify derives its numbers.

How these figures are checked: our methodology and the open dataset.

KEEP YOUR RESEARCH

Is Multiple Myeloma one of your conditions?

Start a free claim-planning workspace. If Multiple Myeloma is yours, you can add it to your list there and pick up where you left off. Nothing is added unless you choose it.

Add it to my free plan

PUT THE PIECES TOGETHER

What could your combined rating look like?

See how Multiple Myeloma combines with your other service-connected conditions using the official VA combined-ratings formula.

Open the free calculator
VA Calc: Disability Pay app icon

VA Calc: Disability Pay

Combine your ratings & see monthly pay on your iPhone · Works offline

Download on theApp Store